Stem Cell Banking Market 2018-2023 - Major Players are Cord Blood Registry Systems, Cordlife Group Limited and Cryo-Cell International

DUBLIN, May 24, 2018 /PRNewswire/ --

The "Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application - Global Forecasts to 2023 " report has been added to ResearchAndMarkets.com's offering.

The global stem cell banking market is projected to reach USD 9.30 Billion by 2023 from USD 6.28 Billion in 2018, at a CAGR of 8.2%

Factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research are driving the growth of the market.

This report broadly categorizes the global stem cell banking market into source, application, service type, and region/country. Based on source, the stem cell banking market is segmented into placental, bone marrow-derived, adipose tissue-derived, human embryo-derived, dental pulp, and other stem cell sources. In 2018, placental stem cells segment is expected to account for the largest share of the market. This can be attributed to the global rise in the number of placental and cord banks (especially in the US and Europe) coupled with growing public awareness about the therapeutic potential of stem cells.

Based on application, the global stem cell banking market is segmented into personalized banking, clinical, and research applications. In 2018, personalized banking applications segment is expected to dominate the global stem cell banking applications market due to the premium pricing of service plans charged by service providers and specific advantages offered by personalized banking over community & public banking, growing adoption of precision medicine across developed countries, rising prevalence of blood and immune system-related disorders, and increasing public concerns regarding the clinical abuse of stored stem cell samples.

Based on service type, the global stem cell banking market is segmented into sample collection & transportation, sample processing, sample analysis, and sample preservation & storage. In 2018, sample preservation & storage segment is expected to be the largest service segment owing to the growing adoption of stem cell banking services in major countries coupled with the rising number of stem cell banks across emerging countries, rising public awareness about the therapeutic applications of stem cells, increasing number of hematopoietic stem cell transplantations, increasing stem cell-based research, and high market penetration of stem cell banking services in major healthcare markets.

In 2018, North America is expected to command the largest share of stem cell banking market that is mainly attributed to the expanding network of stem cell banking services, ongoing approval of stem cell lines for various disease treatment, recent technological advancements in the field of stem cell collection and preservation techniques, rising public-private investments for stem cell researches, growing number of stem cell transplantation procedures, and increasing public preference for private stem cell banking over public stem cell banks.

However, factors such as high operational costs associated with stem cell banking and stringent regulatory frameworks are expected to limit the growth of the stem cell banking market during the forecast period.

As of 2017, major players in the global stem cell banking market are Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), and Cryo-Cell International (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Stem Cell Banking: Market Overview (2018)
4.2 Stem Cell Banking Market, By Source (2018 vs 2023)
4.3 Stem Cell Banking Market, By Application (2018 vs 2023)
4.4 Stem Cell Banking Market, By Service Type (2018 vs 2023)
4.5 Geographic Snapshot: Stem Cell Banking Market (2018)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Awareness on the Therapeutic Potential of Stem Cells
5.2.1.2 Development of Novel Technologies for Stem Cell Preservation, Processing, and Storage
5.2.1.3 Increase in HematopOIEtic Stem Cell Transplantation Procedures
5.2.1.4 Increasing Investments in Stem Cell-Based Research
5.2.2 Market Restraints
5.2.2.1 High Operational Costs of Stem Cell Banking
5.2.2.2 Stringent Regulatory Frameworks
5.2.3 Market Opportunities
5.2.3.1 Emerging Countries
5.2.3.2 Rising Global Burden of Major Diseases
5.2.4 Market Challenge
5.2.4.1 Socio-Ethical Concerns Related to Embryonic Stem Cells

6 Stem Cell Banking Market, By Source
6.1 Introduction
6.2 Placental Stem Cells (PSCS)
6.3 Adipose Tissue-Derived Stem Cells (ADSCS)
6.4 Bone Marrow-Derived Stem Cells (BMSCS)
6.5 Human Embryo-Derived Stem Cells (HESCS)
6.6 Dental Pulp-Derived Stem Cells (DPSCS)
6.7 Other Stem Cell Sources

7 Stem Cell Banking Market, By Service Type
7.1 Introduction
7.2 Sample Preservation and Storage
7.3 Sample Analysis
7.4 Sample Processing
7.5 Sample Collection and Transportation

8 Stem Cell Banking Market, By Application
8.1 Introduction
8.2 Personalized Banking Applications
8.3 Research Applications
8.3.1 Disease Treatment Studies
8.3.2 Life Science Research
8.3.3 Drug Discovery
8.4 Clinical Applications
8.4.1 HematopOIEtic Disorders
8.4.2 Autoimmune Disorders
8.4.3 Other Diseases

9 Stem Cell Banking Market, By Region

10 Competitive Landscape
10.1 Overview
10.2 Global Market Ranking Analysis (2017)
10.3 Competitive Scenario
10.3.1 Agreements, Partnerships, and Collaborations
10.3.2 Mergers and Acquisitions
10.3.3 Service Launches and Enhancements
10.3.4 Other Developments

11 Company Profile
11.1 Cord Blood Registry Systems
11.2 Cordlife
11.3 Cryo-Cell International
11.4 Cryo-Save AG (A Subsidiary of Esperite N.V)
11.5 LifeCell International
11.6 StemCyte
11.7 ViaCord (A Subsidiary of Perkinelmer)
11.8 Global Cord Blood
11.9 Smart Cells International
11.10 Vita34
11.11 CryoHoldco

For more information about this report visit https://www.researchandmarkets.com/research/p4h9fj/stem_cell_banking?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets